首页> Clinical and experimental immunology> Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.

Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.

导出 OA

翻译打印收藏纠错

第一作者： H J,Longhurst

第一单位： Department of Immunology, Barts Health NHS Trust, London, UK.

作者： H J,Longhurst ^[1] ; A,Zanichelli ^[2] ; T,Caballero ^[3] ; L,Bouillet ^[4] ; W,Aberer ^[5] ; M,Maurer ^[6] ; O,Fain ^[7] ; V,Fabien ^[8] ; I,Andresen ^[9] ; IOS Study Group

作者单位： Department of Immunology, Barts Health NHS Trust, London, UK. ^[1] Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Luigi Sacco Hospital Milan, Milan, Italy. ^[2] Department of Allergy, Hospital La Paz Institute for Health Research (IdiPaz), Biomedical Research Network on Rare Diseases (CIBERER, U754), Madrid, Spain. ^[3] National Reference Centre for Angioedema, Internal Medicine Department, Grenoble University Hospital, Grenoble, France. ^[4] Department of Dermatology and Venerology, Medical University of Graz, Graz, Austria. ^[5] Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité-Universitätsmedizin Berlin, Berlin, Germany. ^[6] Department of Internal Medicine, DHU i2B, Saint Antoine Hospital, University Paris 6, Paris, France. ^[7] Shire, Zug, Switzerland at the time of data analysis. Now with Vifor Pharma, Glattbrugg, Switzerland. ^[8] Shire, Zug, Switzerland. ^[9]

关键词 acquired angioedema hereditary angioedema icatibant